Evidence map›Paper›PMID 42281397›Full record

ArticleBriefings in bioinformatics2026

CONTRA-IL6: an interpretable hybrid convolutional neural network and Transformer framework for accurate prediction of interleukin-6-inducing peptides using protein language models.

Duong Thanh Tran, Nhat Truong Pham, Gwang Lee, Shaherin Basith, Balachandran Manavalan

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Duong Thanh TranDepartment of Integrative Biotechnology, College of Biotechnology and Bioengineering, Sungkyunkwan University, Suwon 16419, Gyeonggi-do, Republic of Korea.
Nhat Truong PhamDepartment of Integrative Biotechnology, College of Biotechnology and Bioengineering, Sungkyunkwan University, Suwon 16419, Gyeonggi-do, Republic of Korea.
Gwang LeeDepartment of Physiology, Ajou University School of Medicine, Suwon 16499, Republic of Korea.ORCID 0000-0002-1299-9478
Shaherin BasithDepartment of Physiology, Ajou University School of Medicine, Suwon 16499, Republic of Korea.ORCID 0000-0002-2807-1885
Balachandran ManavalanDepartment of Integrative Biotechnology, College of Biotechnology and Bioengineering, Sungkyunkwan University, Suwon 16419, Gyeonggi-do, Republic of Korea.ORCID 0000-0003-0697-9419

Funding

BK21 FOUR Project, Republic of KoreaCommercialization Promotion Agency for R&D OutcomesDepartment of Integrative Biotechnology, Sungkyunkwan UniversityMinistry of EducationMinistry of Science and ICT RS-2024-00344752Ministry of Science and ICT RS-2024-00416536Ministry of Science and ICT RS-2025-16072961MSIT, Republic of Korea 2710096838National Research Foundation of KoreaSungkyunkwan University and the BK21 FOUR
6 · The paper itself

Abstract

Interleukin-6 (IL-6) is a key immunomodulatory cytokine implicated in diverse physiological processes and pathological conditions, including autoimmune diseases, cancers, and cytokine storms. Immunogenic peptides capable of inducing IL-6 expression are key modulators of host immune responses and represent promising candidates for therapeutic design and epitope-based vaccine development. However, experimental identification of IL-6-inducing peptides remains laborious and unsuitable for large-scale screening. Although existing computational approaches show promise, many often struggle to capture both global contextual semantics and local motif-level features essential for peptide immunogenicity. To address these limitations, we present CONTRA-IL6, a novel deep learning framework that integrates Transformer fusion and convolutional localization modules with stacked pretrained protein language model embeddings to predict IL-6-inducing peptides. Comprehensive benchmarking on an independent dataset demonstrates that CONTRA-IL6 achieves superior predictive performance over six state-of-the-art predictors. Notably, it achieves the highest Matthews correlation coefficient (MCC, 0.504) and F1 (0.549) and improves over the best-performing existing method by 3.2% in MCC and 4.3% in F1, demonstrating balanced and robust performance. Feature space visualizations (uniform manifold approximation and projection, kernel density estimation) showed clear class separation, while 1D gradient-weighted class activation mapping++ highlighted strong attention to specific C-terminal regions. Crucially, we moved beyond these attribution methods by employing in silico mutagenesis, which causally confirmed the functional importance and physicochemical constraints. Ablation studies further confirmed the synergistic contribution of global and local modules to model performance. CONTRA-IL6 offers a robust, scalable, and interpretable solution for immunoinformatics research. The standalone package is freely available at https://pypi.org/project/contra-il6/ to facilitate broader community use.

Indexed as

Interleukin-6PeptidesComputational BiologyConvolutional Neural NetworksDeep LearningHumansImmunoinformaticsPrediction AlgorithmsInterleukin-6Peptidesconvolutional neural networksdeep learningIL-6-inducing peptidesimmunotherapyprotein language modelTransformer

Identifiers

PMID42281397
PMCPMC13256231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.